CRISPR THERAPEUTICSCS AG
CRISPR THERAPEUTICSCS AG
Aktie · CH0334081137 · CRSP · A2AT0Z (XNMS)
Übersicht Finanzkennzahlen
41,90 USD
8,69 % 3,35 USD
NASDAQ/NMS (GLOBAL MARKET) (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 23:57

Aktuelle Kurse von CRISPR THERAPEUTICSCS AG

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
CRSP
USD
06.06.2025 23:57
41,90 USD
38,57 USD
+8,63 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 14,48 % 26,35 % -3,26 % -19,93 % -30,12 % -32,70 %

Firmenprofil zu CRISPR THERAPEUTICSCS AG Aktie

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company's lead product candidate is CTX001, an ex vivo CRISPR gene-edited therapy for treating patients suffering from transfusion-dependent beta-thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. It also develops CTX110, a donor-derived gene-edited allogeneic CAR-T investigational therapy targeting cluster of differentiation 19 positive malignancies; CTX120, a donor-derived gene-edited allogeneic CAR-T investigational therapy targeting B-cell maturation antigen for the treatment of relapsed or refractory multiple myeloma; and CTX130, a donor-derived gene-edited allogeneic CAR-T investigational therapy targeting Cluster of Differentiation 70 to treat various solid tumors and hematologic malignancies. In addition, the company develops VCTX210, a gene-edited immune-evasive stem cell-derived product candidate for the treatment of treatment of type 1 diabetes; and pursues various in vivo gene-editing programs that target the liver, lung, muscle, and central nervous system diseases. It has strategic partnerships with Bayer Healthcare LLC, Vertex Pharmaceuticals Incorporated, ViaCyte, Inc., Nkarta, Inc., and Capsida Biotherapeutics. CRISPR Therapeutics AG was incorporated in 2013 and is headquartered in Zug, Switzerland.

Investierte Fonds

Folgende Fonds haben in investiert: CRISPR THERAPEUTICSCS AG investiert:

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in Mio
318,68
Anteil (%)
0,75 %

Unternehmensdaten

Name CRISPR THERAPEUTICSCS AG
Firma CRISPR Therapeutics AG
Symbol CRSP
Website https://www.crisprtx.com
Heimatbörse XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A2AT0Z
ISIN CH0334081137
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Samarth Kulkarni Ph.D.
Marktkapitalisierung 3 Mrd.
Land Schweiz
Währung USD
Mitarbeiter 0,4 T
Adresse Baarerstrasse 14, 6300 Zug
IPO Datum 2016-10-19

Ticker Symbole

Name Symbol
Frankfurt 1CG.F
NASDAQ CRSP

Weitere Aktien

Investoren die CRISPR THERAPEUTICSCS AG die halten, haben auch folgende Aktien im Depot:
AIS-AM.MSCI E.M.V.F. EOC
AIS-AM.MSCI E.M.V.F. EOC ETF
AMAZON.CO INC
AMAZON.CO INC Aktie
BAYER AG
BAYER AG Aktie
BIONTECH SE ADR
BIONTECH SE ADR Aktie
CENTR.GARDEN 20/30
CENTR.GARDEN 20/30 Anleihe
MICROSOFT CORP
MICROSOFT CORP Aktie
PACIFIC BIOSCIENCES OF CALIFA INC
PACIFIC BIOSCIENCES OF CALIFA INC Aktie
PAYPAL INC
PAYPAL INC Aktie
POLYUS FINANCE 18/24 REGS
POLYUS FINANCE 18/24 REGS Anleihe
SAP SE
SAP SE Aktie
SHOPIFY A SUB.VTG
SHOPIFY A SUB.VTG Aktie
SQUARE INC A
SQUARE INC A Aktie
TESLA INC
TESLA INC Aktie
WALT DISNEY INC
WALT DISNEY INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025